On May 9, the FDA warned that unless it gets additional authority to regulate compounding facilities, we will likely see a recurrence of the multistate meningitis outbreak that killed nearly 50 people and sickened more than 700. In the meantime, though, the FDA has followed through on its promise to inspect “high-risk” facilities, which has already resulted in four recalls from compounding centers in Georgia, Florida, and New Jersey.
The Ongoing Impact of the Fungal Meningitis Outbreak
The CDC continues to identify new cases related to contamination at the New England Compounding Center (NECC). Ten new cases were identified in April, and officials warn that the incubation period for the disease is longer than anticipated. Many of the new cases are showing up in people who previously tested infection-free.
Based on previous cases, mostly a 2002 outbreak of the disease, officials believed that infections should show up within about five months after exposure. With new cases continuing to show up every week, more than six months after the contaminated injections were pulled from the market, officials now admit they have little experience with this type of infection, though they hopefully state that slow-growing infections should be less serious than the serious meningitis cases, which showed up quickly.
Are you in need of a medical liability lawyer?
No comments:
Post a Comment